Diabetes Types 1 and 2: Management Strengths and Complication Risks

Type 1 Diabetes (T1D)

  • Pathophysiology: Autoimmune β-cell destruction → absolute insulin deficiency
  • Onset: Typically childhood/adolescence; can occur at any age
  • Management: Insulin (basal-bolus MDI or pump), CGM, carb counting
  • Strengths: Predictable insulin requirement; technology (AID systems) enables near-physiologic control

Type 2 Diabetes (T2D)

  • Pathophysiology: Insulin resistance + progressive β-cell dysfunction
  • Onset: Typically adult; rising in youth with obesity
  • Management: Lifestyle → metformin → GLP-1 RA/SGLT2i → insulin
  • Strengths: Often preventable/delayable; multiple drug classes with CV/renal benefits

Shared Complication Risks (If Uncontrolled)

  • Microvascular: Retinopathy, nephropathy, neuropathy
  • Macrovascular: CAD, stroke, PAD (2–4× risk)
  • Infections, poor wound healing
  • Hypoglycemia (treatment-induced)
  • Diabetic ketoacidosis (T1D) / HHS (T2D)

Keys to Long-Term Health

  • A1c <7% individualized
  • BP <130/80, LDL <70 (or <55 if ASCVD)
  • SGLT2i/GLP-1 RA for cardio-renal protection
  • Annual eye, foot, kidney screening
  • Diabetes self-management education (DSMES)

Diabetes - Related Articles